top of page
PT-141, also known as bremelanotide, is a synthetic peptide analog of alpha-MSH used to enhance sexual desire and function. It is FDA-approved for treating hypoactive sexual desire disorder (HSDD) in premenopausal women. PT-141 works by stimulating melanocortin receptors in the brain, particularly MC3R and MC4R, which are involved in sexual arousal and function. 

PT-141 10mg

$34.95Price
Quantity

  • Here's a more detailed explanation:

    • Clinical Uses:

      PT-141 is specifically approved for treating HSDD in premenopausal women. It has also shown potential for improving sexual function in men. 

    • Administration:

      PT-141 is typically administered as a subcutaneous injection. 

    • Dosage:

      The dosage of PT-141 can vary depending on individual needs and responses, and is generally determined by a healthcare professional. 

    • Side Effects:

      Some potential side effects of PT-141 include flushing, nausea, headache, and temporary skin darkening. 

    • Important Considerations:

      PT-141 is not recommended for individuals with cardiovascular disease or uncontrolled hypertension due to potential increases in blood pressure. It also requires a prescription from a healthcare provider. 

    • Mechanism of Action:

      PT-141 acts as an agonist, meaning it activates melanocortin receptors. These receptors play a role in various brain functions, including sexual arousal and desire. 

bottom of page